NeurologyWire

AbbieVie Receives Approval for Carbidopa and Levodopa Pump

From NeurologyWire

FDA has approved Duopa (carbidopa and levodopa) enteral suspension for the treatment of motor fluctuations for people with advanced Parkinson's disease. Duopa is administered using a small, portable infusion pump that delivers carbidopa and levodopa directly into the small intestine for 16 continuous hours via a procedurally-placed tube.It was appr...

Login to read story

Wednesday, February 18, 2015

Show last days of articles

Small Study Shows Promising Results for New Alzheimer's Ther...

From NeurologyWire

Scientists at Karolinska Institutet have evaluated a new Alzheimer's therapy in which the patients receive an implant that stimulates the growth of a ...Full story

New Drug Target for Multiple Sclerosis

From NeurologyWire

Scientists at the Centre for Addiction and Mental Health (CAMH) have discovered a new approach to treat multiple sclerosis (MS). In a new study, they'...Full story

Tuesday, February 17, 2015

Study: Dogs Know That Smile on Your Face

From NeurologyWire

Dogs can tell the difference between happy and angry human faces, according to a new study in the Cell Press journal Current Biology on February 12. T...Full story

The Neural Basis of 'Being in the Mood'

From NeurologyWire

What determines receptivity or rejection towards potential sexual partners? For people, there are many factors that play a part, appearance, culture, ...Full story

ALS Trial Reaches Halfway Point in Patient Enrollment

From NeurologyWire

MediciNova announced that the ongoing clinical trial of MN-166 (ibudilast) in amyotrophic lateral sclerosis (ALS) has enrolled 30 of the 60 subjects p...Full story

Analysis Shows Benefits of Endovascular Therapy for Severe S...

From NeurologyWire

A pooled analysis of two recent clinical trials involving the use of devices to treat stroke-causing blood clots indicates that patients with the most...Full story

Friday, February 13, 2015

Study: Physicians Report Few Requests By Patients For Unnece...

From NeurologyWire

By Shefali LuthraKaiser Health NewsThough medically unnecessary tests and procedures are often blamed for the nations high health care costs, patients...Full story

FDA Permits Marketing of Fecal Incontinence Device for Women

From NeurologyWire

FDA will allow marketing of the Eclipse System for the treatment of fecal incontinence (FI) in adult women.Fecal incontinence is the inability to cont...Full story

Findings Do Not Support Creatine for Parkinson's Prescriptio...

From NeurologyWire

New findings do not support the use of creatine monohydrate in patients with Parkinson disease. Published published in the Feb. 10 issue of the Journa...Full story

Wednesday, February 11, 2015

The Brain Develops Abnormally for People Who Stutter

From NeurologyWire

A region of the brain thought to control speech production develops abnormally in children who stuttera pattern that persists into adulthood, accordin...Full story

Positive Results From Phase I Study of Multiple Sclerosis Tr...

From NeurologyWire

Alkermes has released positive topline results from a phase I, randomized, double-blind clinical study of ALKS 8700, a novel monomethyl fumarate (MMF)...Full story

New Data Supports Vepoloxamer In Embolic Stroke

From NeurologyWire

In a model of embolic stroke with delayed administration of tissue plasminogen activator (tPA), treatment with vepoloxamer (MST-188), both alone and i...Full story

Howard Fine Named Founding Director of the Brain Tumor Cente...

From NeurologyWire

Dr. Howard Fine has been appointed to lead the newly established neuro-oncology program at NewYork-Presbyterian Hospital/Weill Cornell Medical Center,...Full story

Tuesday, February 10, 2015

Phase IIa Study of Frontotemporal Dementia Doses First Patie...

From NeurologyWire

Forum Pharmaceuticals announced dosing of the first patient in a Phase IIa proof of mechanism clinical trial to evaluate the company's investigational...Full story

FDA Approves New Device Aimed at Easing Stroke Risk

From NeurologyWire

FDA has cleared for marketing the ENROUTE Transcarotid Neuroprotection System (ENROUTE TNS), for use during a minimally invasive procedure to restore ...Full story